Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole adjuvant therapy after tamoxifen in postmenopausal early breast cancer
2005-001213-18Phase 3Active
- Sponsor
- Consorzio Oncotech
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of letrozole in breast cancer, sponsored by Consorzio Oncotech. Primary endpoint: Clinical efficacy of adjuvant letrozole. Started Sep 2005; status: active.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001213-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001213-18.